Clinical trials
Kidney Diseases clinical trials
Below are recruiting kidney diseases clinical trials, each written for real people, not researchers. We’re tracking 686 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07662889Enrolling by invitation
Comparing two types of dialysis for kidney failure
This trial compares a newer type of dialysis called hemodiafiltration with standard hemodialysis to see if it improves certain health measures in people with end-stage kidney disease. It may help determine which method works better for long-term treatment.
Lahore, Punjab ProvinceAges 18–70 - NCT07292493Enrolling by invitation
Immune system study for diabetic kidney disease
This study looks at how the immune system works in people with diabetic kidney disease. It tests whether certain blood pressure medicines can help protect the kidneys.
LjubljanaAges 40–65 - NCT07102667Enrolling by invitation
Protein intake for muscle health in older kidney patients
This study tests how much protein older adults with kidney disease and muscle loss should eat to build or maintain muscle. You will follow a protein plan and do simple resistance exercises to see if it helps your strength.
BangkokAges 65 years+ - NCT05764642Enrolling by invitationPhase 2
Ultrasound imaging of kidney blood vessels in kidney disease
This Phase 2 study tests an ultrasound imaging method to look at tiny blood vessels in the kidneys. It may help doctors better understand chronic kidney disease, especially when a kidney biopsy is already planned for medical reasons.
Jacksonville, FloridaAges 18 years+ - NCT07043166Recruiting
Heart, kidney, and metabolic health study in Shanghai
This study looks at the link between heart, kidney, and metabolic health in adults living in Shanghai. It follows people who were part of an earlier health study to see how their health changes over time.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT05457283RecruitingPhase 3
Finerenone safety study for children with kidney disease
This trial studies how safely finerenone works over 18 months in children and young adults with chronic kidney disease who also take an ACE inhibitor or ARB. It aims to better understand long-term side effects when used together with standard kidney blood-pressure medicines.
Palo Alto, CaliforniaAges 1–18 - NCT06824987RecruitingPhase 2
Study of AZD2373 for APOL1-related kidney disease
This trial tests an experimental drug (AZD2373) for people with kidney disease caused by APOL1 gene changes. It aims to find the safest and most effective dose to slow kidney damage.
Alabaster, AlabamaAges 18–65 - NCT07666815RecruitingPhase 1/Phase 2
Exercise and creatine during dialysis for kidney disease
This trial tests if doing exercise while on dialysis and taking creatine can help people with chronic kidney disease. It aims to find a safe and effective way to improve health during treatment.
Colima, ColiimaAges 18 years+ - NCT07228364RecruitingPhase 1
Testing safety of AZD1613 for polycystic kidney disease
This trial tests a new study drug called AZD1613 for adults with a certain type of kidney disease (ADPKD). Researchers want to see if it is safe, how the body handles it, and what the right dose might be.
Birmingham, AlabamaAges 18–65 - NCT04741646RecruitingPhase 2
Ferric citrate for kids with chronic kidney disease
This Phase 2 study tests ferric citrate, a medicine that helps control phosphate and iron balance, in children with chronic kidney disease. It may help slow problems related to kidney disease by improving lab measures like phosphate levels.
Los Angeles, CaliforniaAges 6–18 - NCT05656261Recruiting
Genetic testing study for African Americans
This study looks at genetic markers (genes) related to kidney risk in Black/African American adults. It may help researchers better understand who is at higher risk and how genetics could guide future care.
St Louis, MissouriAges 18–90 - NCT05846490RecruitingPhase 4
Sleep apnea treatment to improve blood pressure in kidney disease
This study tests whether treating obstructive sleep apnea can help control blood pressure in people with chronic kidney disease. If your sleep apnea is not currently being treated, participation may help your care team see whether safer breathing at night improves blood pressure control.
São PauloAges 18 years+ - NCT06155604RecruitingPhase 2
SGLT2 inhibitor for lupus nephritis with kidney disease
This study tests if an SGLT2 inhibitor can help protect kidney function in people who have lupus nephritis (kidney inflammation caused by lupus) and chronic kidney disease (CKD). The goal is to see if this medicine can slow down further kidney damage.
Hong KongAges 18 years+ - NCT06364358Recruiting
Interactive kidney disease education program for African Americans
This study is testing a computer-based education program for African American patients with chronic kidney disease. It aims to help you better understand your condition and treatment options.
Chicago, IllinoisAges 18–70 - NCT06372743Recruiting
Nurse-led care for kidney disease with other health issues
This study tests a nurse-led care model with doctor support for people with chronic kidney disease who also have other health problems like high blood pressure or diabetes. Its goal is to help you better manage your health and avoid complications.
SingaporeAges 21 years+ - NCT06435858RecruitingPhase 2
SGLT2 inhibitor for calcium and magnesium in ADPKD
This study tests whether a medicine called an SGLT2 inhibitor (a type of diabetes drug) can help control calcium and magnesium levels in people with a genetic kidney disease called ADPKD. The goal is to see if it improves kidney health over a short period.
Zurich, Canton of ZurichAges 18–75 - NCT07619820RecruitingPhase 1
CSL300 Safety Study for Kidney Dialysis Patients
This study tests how a new drug called CSL300 (clazakizumab) works in the body of people with end-stage kidney disease who are on dialysis. Researchers want to understand if it's safe and how your body processes it.
BeijingAges 18 years+ - NCT06799936Recruiting
Helping older kidney patients decide on treatment with their doctor
This trial tests a program that helps older adults with advanced kidney disease talk with their doctors about treatment options. The goal is to improve shared decision-making before they need dialysis or a transplant.
Hong KongAges 65 years+ - NCT06810258Recruiting
Biomarkers before and after kidney transplant
This study will collect blood samples from people having a kidney biopsy or a kidney transplant to look for biomarkers (biological signs) that can give doctors more information about kidney health. Participating may help doctors better understand and treat kidney disease in the future.
CréteilAges 18 years+ - NCT07231679RecruitingPhase 1/Phase 2
Testing IGT-303 for kidney disease from diabetes
This study tests a new drug called IGT-303 for people with chronic kidney disease caused by type 2 diabetes. It aims to see if the drug is safe and can help protect kidney function.
Herston, BrisbaneAges 18–75 - NCT06741072RecruitingPhase 1
Vaccine to prevent EBV-related cancer in transplant patients
This trial tests a vaccine (OSU-2131) that may help prevent cancers caused by the Epstein-Barr virus in people waiting for an organ transplant. The vaccine is designed to train your immune system to fight the virus.
Columbus, OhioAges 18–65 - NCT07260071Recruiting
High blood pressure in kids at risk for inherited kidney disease
This study looks for early signs of high blood pressure in children and teens (12–17) who have a parent with ADPKD, a kidney condition. It uses non-invasive tests like blood pressure monitoring and MRI to track kidney health.
LondonAges 12–17 - NCT00792155Recruiting
Register people with diagnosed ADPKD to build a kidney data resource
This trial builds a secure database by collecting information from adults who already have autosomal dominant polycystic kidney disease (ADPKD). Your information can help researchers understand the condition better and improve future care.
New York, New YorkAges 18 years+ - NCT07454174Recruiting
Study of a dietary program for polycystic kidney disease
This study tests a special medical food (Ren-Nu) to see if it helps with metabolism and kidney health in people with ADPKD. You would follow a dietary program and attend online classes.
Cleveland, OhioAges 18 years+
Hear when a new Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for kidney diseases?
- Yes. Clin2 currently lists 686 recruiting kidney diseases studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a kidney diseases trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a kidney diseases trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.